New Zealand’s women beat newly-crowned world sevens series champions Australia 21-14 in the final leg in Toulouse.
Blog Page 3
Shanghai-based Excalipoint secures rights to two preclinical T-cell engagers from Lepu Biopharma, aiming to fast-track development for solid tumors and hematologic malignancies.
With a fresh $153 million in funding, Strand Therapeutics is pushing the boundaries of mRNA technology—this time, in the fight against cancer
Generative AI has produced a novel TNIK-inhibiting compound now advancing in phase 2a trials—an unprecedented milestone in drug discovery.
A phase 1 pilot trial suggests that a novel egg-shell derived peptide may reduce Alzheimer’s biomarkers and improve memory in mild Alzheimer’s patients
New Zealand’s women beat newly-crowned world sevens series champions Australia 21-14 in the final leg in Toulouse.
One company faces regulatory setback while another achieves a Phase III victory, highlighting both urgency and uncertainty in drug development
Regulatory setback for one biotech contrasts with a major success in sleep disorder treatment, underscoring the high stakes in clinical development
A new collaboration aims to develop VMX-C001 to treat severe bleeding in patients on anticoagulants, targeting a 2029 launch
Early results from a multi-centre trial indicate that BI-8721 may slow cognitive decline and reduce amyloid biomarkers in people with mild Alzheimer’s